A groundbreaking study led by scientists from the Institute for Bioengineering of Catalonia (IBEC) and West China Hospital of Sichuan University has shown that a new nanotechnology-based treatment can reverse Alzheimer’s disease in mice.
This discovery offers a completely new way to think about treating one of the world’s most devastating brain diseases.
Unlike traditional drug treatments, which focus on targeting brain cells directly, this approach repairs the brain’s protective shield — the blood-brain barrier (BBB).
The BBB acts like a security gate, allowing nutrients to reach the brain while keeping out toxins and harmful substances.
When this barrier is damaged, it can no longer clear toxic waste efficiently, which contributes to Alzheimer’s disease. Restoring its function may help the brain heal itself.
What makes this study unique is the use of “supramolecular drugs” — nanoparticles that are active medicines on their own, not just carriers for other drugs.
These nanoparticles were engineered to help the BBB remove harmful proteins linked to Alzheimer’s disease, such as amyloid-beta (Aβ). When Aβ builds up, it forms sticky clumps in the brain that damage neurons and interfere with memory and thinking.
In experiments using mice genetically modified to develop Alzheimer’s-like symptoms, the researchers administered just three doses of the new nanoparticles. Within one hour, the amount of amyloid-beta in the brain dropped by about 50–60 percent.
Even more impressive, the long-term results showed that mice treated with the therapy regained normal behavior and memory functions. A 12-month-old mouse, roughly the equivalent of a 60-year-old human, showed full recovery after six months of treatment.
According to lead researcher Professor Giuseppe Battaglia from IBEC, the key lies in repairing the brain’s vascular system. When the blood vessels start working normally again, the brain can clear away toxic proteins naturally.
It’s like restarting a cleaning system that had broken down. Once the brain’s balance is restored, the entire system begins to heal.
The process works by resetting a natural protein called LRP1, which normally helps transport waste proteins out of the brain. In Alzheimer’s disease, this system becomes clogged, and the brain loses its ability to clear harmful material.
The supramolecular nanoparticles act like a reset button — they mimic the molecules that LRP1 usually binds to, allowing amyloid-beta to move safely through the barrier and into the bloodstream for removal.
This technique doesn’t just reduce toxic buildup; it also repairs the blood vessels and helps them work properly again. The researchers call this a cascade effect, where improving one function helps the rest of the brain recover.
This dual benefit — clearing toxins and restoring blood flow — could make this nanotechnology one of the most promising treatments ever tested in animal models of Alzheimer’s.
The nanoparticles were built using a technique known as molecular engineering, allowing scientists to design them with exact sizes and surface structures.
This precision lets them interact with specific receptors on brain cells and blood vessel walls in a highly controlled way. Because of this, the treatment works quickly and effectively, with very little interference to the brain’s natural processes.
According to Dr. Lorena Ruiz Perez, one of the researchers from IBEC, this discovery marks a major step forward. The nanoparticles not only removed amyloid-beta from the brain but also restored normal blood-brain barrier function, leading to a complete reversal of Alzheimer’s symptoms in mice.
She emphasized that this could open the door to a new generation of therapies that focus on repairing the brain’s vascular system rather than just targeting neurons.
The study was carried out by a large international team, including scientists from Spain, China, and the UK. The findings were published in the journal Signal Transduction and Targeted Therapy.
While this study is still in the early stages and was only done in mice, it represents a major breakthrough in Alzheimer’s research. The results show that targeting the blood-brain barrier could be as important as targeting the brain cells themselves.
If future studies in humans confirm these results, this nanotech approach could become a completely new way to treat Alzheimer’s disease.
Overall, this study provides hope that Alzheimer’s may one day be reversible — not just slowed down — if the right biological systems in the brain can be repaired and reactivated. It’s an exciting step forward in the long search for a cure.
If you care about Alzheimer’s, please read studies about the likely cause of Alzheimer’s disease , and new non-drug treatment that could help prevent Alzheimer’s.
For more health information, please see recent studies about diet that may help prevent Alzheimer’s, and results showing some dementia cases could be prevented by changing these 12 things.
The study is published in Signal Transduction and Targeted Therapy.
Copyright © 2025 Knowridge Science Report. All rights reserved.
